The first-generation ABSORB BVS: awaiting dissolving outcomes
نویسندگان
چکیده
منابع مشابه
The first-generation ABSORB BVS: awaiting dissolving outcomes
We thank Dr Shah for his response to our meta-analysis. As Dr Shah points out, in our meta-analysis the ABSORB II trial was the only study that reported 3-year follow-up. All the other trials had a follow-up duration of 2 years or less, and the AIDA trial reported a median follow-up of 2 years [1]. Therefore, the very-long-term clinical efficacy and safety of the bioresorbable vascular scaffold...
متن کاملThe first generation ABSORB BVS scaffold; to be or not to be?
In the routine treatment of coronary artery disease, balloon angioplasty has been replaced by stents. The use of bare-metal stents resulted in lower rates of restenosis and repeat revascularisations. Drug-eluting stents (DES), designed with thinner struts and anti-proliferative drugs, have further enhanced the efficacy and safety of percutaneous coronary intervention. Nevertheless, the new gene...
متن کاملBiodegradable vascular scaffold ABSORB BVS™ – scientific evidence and methods of implantation
Since 2006, over 600 biodegradable vascular scaffolds (BVS) have been implanted worldwide in clinical trials such as ABSORB cohort A and B, ABSORB Extend and ABSORB II RCT. Due to completely changed construction and mechanical properties of BVS, the choice of proper scaffold diameter and its implantation differ significantly from those used in the case of metal stents (bare metal stent (BMS) or...
متن کاملBioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan
Bioresorbable polymers and biocorrodible metals are the latest developments in biodegradable materials used in interventional cardiology for the mechanical treatment of coronary atherosclerosis. Poly-L-lactic acid is the most frequently used bioresorbable polymer and initial evidence of feasibility, efficacy and clinical safety following deployment of polymer-based platforms was gained after co...
متن کاملThree-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
BACKGROUND The Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3 years after coronary artery implantation. The safety and effectiveness of BVS through this critical 3-year period have not been characterized. METHODS We performed an individual-patient-data pooled meta-analysis of the 4 randomized ABSORB trials in which 3389 patients with coronary artery disease were rand...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Netherlands Heart Journal
سال: 2017
ISSN: 1568-5888,1876-6250
DOI: 10.1007/s12471-017-1042-8